PRF Technologies PRFX
NASDAQ PRFX
$0.76 +0.05 (+6.71%)
As of: Oct 20, 2026 · 2:16 PM EDT

PRF Technologies (PRFX) Non-Current Debt (2019 - 2020)

Updated

Analysis

PRF Technologies (PRFX) Non-Current Debt (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,149.93 Bn 1,118.52 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 625.23 Bn 543.75 Bn 17.26 Bn 37.34 Bn
3 AbbVie 512.30 Bn 485.41 Bn 12.70 Bn 62.48 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 23.68 Bn
7 Amgen 235.12 Bn 190.52 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.40 Bn 168.60 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn 60.50 Bn
10 PRF Technologies 492,329.90 -22.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 3.93 Mn
Dec 31, 2019 3.93 Mn
API Access

PRF Technologies Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PRFX&period=max&api_key=YOUR_API_KEY